BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 16948814)

  • 21. NF-KappaB expression correlates with apoptosis and angiogenesis in clear cell renal cell carcinoma tissues.
    Meteoglu I; Erdogdu IH; Meydan N; Erkus M; Barutca S
    J Exp Clin Cancer Res; 2008 Oct; 27(1):53. PubMed ID: 18928570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of vascular endothelial growth factor and receptor flk-1 in colon cancer liver metastases.
    Cheng J; Slavin RE; Gallagher JA; Zhu G; Biehl TR; Swanstrom LL; Hansen PD
    J Hepatobiliary Pancreat Surg; 2004; 11(3):164-70. PubMed ID: 15235888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. VEGF, VEGFRs expressions and activated STATs in ovarian epithelial carcinoma.
    Chen H; Ye D; Xie X; Chen B; Lu W
    Gynecol Oncol; 2004 Sep; 94(3):630-5. PubMed ID: 15350351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of angiogenesis, p-53 tissue protein expression and serum VEGF in patients with endometrial cancer.
    Mazurek A; Pierzyński P; Kuć P; Kopinski P; Terlikowski S; Niklińska W; Trojan J; Laudański T
    Neoplasma; 2004; 51(3):193-7. PubMed ID: 15254672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with 5-fluorouracil and cis-platinum.
    Boku N; Chin K; Hosokawa K; Ohtsu A; Tajiri H; Yoshida S; Yamao T; Kondo H; Shirao K; Shimada Y; Saito D; Hasebe T; Mukai K; Seki S; Saito H; Johnston PG
    Clin Cancer Res; 1998 Jun; 4(6):1469-74. PubMed ID: 9626464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer.
    Yao JC; Wang L; Wei D; Gong W; Hassan M; Wu TT; Mansfield P; Ajani J; Xie K
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4109-17. PubMed ID: 15217947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of vascular endothelial growth factor in salivary gland carcinomas and its relation to p53, Ki-67 and prognosis.
    Lim JJ; Kang S; Lee MR; Pai HK; Yoon HJ; Lee JI; Hong SP; Lim CY
    J Oral Pathol Med; 2003 Oct; 32(9):552-61. PubMed ID: 12969230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of survivin in gastric cancer and its relationship with tumor angiogenesis.
    Lee GH; Joo YE; Koh YS; Chung IJ; Park YK; Lee JH; Kim HS; Choi SK; Rew JS; Park CS; Kim SJ
    Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):957-63. PubMed ID: 16894308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. JAK2/STAT3 signaling pathway activation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-small-cell lung cancer.
    Zhao M; Gao FH; Wang JY; Liu F; Yuan HH; Zhang WY; Jiang B
    Lung Cancer; 2011 Sep; 73(3):366-74. PubMed ID: 21333372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of vascular endothelial growth factor, receptor KDR and p53 protein in transitional cell carcinoma of the bladder.
    Liu L; Zhu D; Gao R; Guo H
    Urol Int; 2008; 81(1):72-6. PubMed ID: 18645275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of Stat3, HIF-1alpha and VEGF in Wilms' tumor].
    Niu ZB; Wang CL; Hou Y; Yang Y; Gao H
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):461-4. PubMed ID: 17937859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Constitutive activation of signal transducers and activators of transcription 3 correlates with better prognosis, cell proliferation and hypoxia-inducible factor-1α in human gastric cancer.
    Woo S; Lee BL; Yoon J; Cho SJ; Baik TK; Chang MS; Lee HE; Park JW; Kim YH; Kim WH
    Pathobiology; 2011; 78(6):295-301. PubMed ID: 22104200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Correlation of tissue factor expression to angiogenesis of gastric carcinoma and its clinical significance].
    Jiao ZY; Gou CZ; Cao N; Li YM
    Ai Zheng; 2005 Jul; 24(7):880-4. PubMed ID: 16004820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiogenesis, p53, and bcl-2 expression as prognostic indicators in endometrial cancer: comparison with traditional clinicopathologic variables.
    Erdem O; Erdem M; Dursun A; Akyol G; Erdem A
    Int J Gynecol Pathol; 2003 Jul; 22(3):254-60. PubMed ID: 12819392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical expression of the cyclooxygenase-2 (COX-2) in gastric cancer. The correlations with the tumor angiogenesis and patients' survival.
    Lazăr D; Tăban S; Ardeleanu C; Simionescu C; Sporea I; Cornianu M; Vernic C
    Rom J Morphol Embryol; 2008; 49(3):371-9. PubMed ID: 18758643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and clinical significance of vascular endothelial growth factor, cyclooxygenase-2, and Bcl-2 in borderline ovarian tumors.
    Li M; Qi SY; Wang Y; Feng SX; Zhang BZ; Wang R
    Arch Gynecol Obstet; 2005 Jun; 272(1):48-52. PubMed ID: 15682318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and activation of the nerve growth factor receptor TrkA in serous ovarian carcinoma.
    Davidson B; Reich R; Lazarovici P; Nesland JM; Skrede M; Risberg B; Tropé CG; Flørenes VA
    Clin Cancer Res; 2003 Jun; 9(6):2248-59. PubMed ID: 12796393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides.
    Weerasinghe P; Garcia GE; Zhu Q; Yuan P; Feng L; Mao L; Jing N
    Int J Oncol; 2007 Jul; 31(1):129-36. PubMed ID: 17549413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maspin expression in early oral tongue cancer and its relation to expression of mutant-type p53 and vascular endothelial growth factor (VEGF).
    Cho JH; Kim HS; Park CS; Kim JK; Jung KY; Shin BK; Kim HK
    Oral Oncol; 2007 Mar; 43(3):272-7. PubMed ID: 17174141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of vascular endothelial growth factor, mitogen-activated protein kinase and p53 in human colorectal cancer.
    Cassano A; Bagalà C; Battelli C; Schinzari G; Quirino M; Ratto C; Landriscina M; Barone C
    Anticancer Res; 2002; 22(4):2179-84. PubMed ID: 12174901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.